Statins as a newly recognized type of immunomodulator.

Kwak, Brenda, Mulhaupt, Flore, Myit, Samir, Mach, François·2000·Nature Medicine
DOI 10.1038/82219

Cited by (1,001)

Items 401–500 of 1,001

  1. Melatonin synergistically enhances protective effect of atorvastatin against gentamicin-induced nephrotoxicity in rat kidney
    Saeed Mehrzadi, Seyed Kamran Kamrava, Banafshe Dormanesh, Manijeh Motevalian, Azam Hosseinzadeh, Seyed Mohammad Taghi Hosseini Tabatabaei, Habib Ghaznavi · 2015 · Canadian Journal of Physiology and Pharmacology
  2. Statins inhibit NK cell cytotoxicity by membrane raft depletion rather than inhibition of isoprenylation
    Dianne Z. Hillyard, Cian D. Nutt, Jacqueline Thomson, Kenneth J McDonald, Ray K. Wan, Angus J.M. Cameron, Patrick Barry Mark, Alan G. Jardine · 2006 · Atherosclerosis
  3. Statin Attenuates Experimental Anti-Glomerular Basement Membrane Glomerulonephritis Together with the Augmentation of Alternatively Activated Macrophages
    Emiko Fujita, Akira Shimizu, Yukinari Masuda, Naomi Kuwahara, Takashi Arai, Shinya Nagasaka, Kaoru Aki, Akiko Mii, Yasuhiro Natori, Yasuhiko Iino et al. · 2010 · American Journal Of Pathology
  4. Changes in Outcomes of Cardiac Allograft Vasculopathy Over 30 Years Following Heart Transplantation
    Maxime Tremblay‐Gravel, Normand Racine, Simon de Denus, Anique Ducharme, Guy B. Pelletier, Geneviève Giraldeau, Mark Liszkowski, Marie-Claude Parent, Michel Carrier, Annik Fortier et al. · 2017 · JACC Heart Failure
  5. Statins: effects beyond cholesterol lowering
    Ziad A. Massy, Carlos Guijarro · 2001 · Nephrology Dialysis Transplantation
  6. Zygomycosis and diabetes mellitus
    Fanny Lanternier, Olivier Lortholary · 2009 · Clinical Microbiology and Infection
  7. Effects of statins on microglia
    Catharina Lindberg, Milita Crisby, Bengt G. Winblad, Marianne Schultzberg · 2005 · Journal of Neuroscience Research
  8. Atorvastatin attenuates TLR4-mediated NF-kappaB activation in a MyD88-dependent pathway.
    Praveen Chansrichavala, Udom Chantharaksri, Piyamitr Sritara, Sansanee C. Chaiyaroj · 2009 · PubMed
  9. Chapter 2 The Potential Role of Heat Shock Proteins in Cardiovascular Disease
    Majid Ghayour‐Mobarhan, Amir Ali Rahsepar, Shima Tavallaie, Sara Rahsepar, Gordon A. Ferns · 2009 · Advances in clinical chemistry
  10. Statins reduce endothelial cell apoptosis via inhibition of TRAIL expression on activated CD4 T cells in acute coronary syndrome
    Kayoko Sato, Toshiyuki Nuki, Keiko Gomita, Cornelia M. Weyand, Nobuhisa Hagiwara · 2010 · Atherosclerosis
  11. Topical Simvastatin as Host-Directed Therapy against Severity of Cutaneous Leishmaniasis in Mice
    Suraj P. Parihar, Mary‐Anne Hartley, Ramona Hurdayal, Reto Guler, Frank Brombacher · 2016 · Scientific Reports
  12. Lymphocyte function antigen‐1 mediates leukocyte adhesion and subsequent liver damage in endotoxemic mice
    Xiang Li, Daniel Klintman, Gabriele Weitz‐Schmidt, René Schramm, Henrik Thorlacius · 2004 · British Journal of Pharmacology
  13. New insights into adaptive immunity in chronic neuroinflammation.
    V. Siffrin, A. Brandt, J. Herz, F. Zipp · 2007 · Advances in Immunology
  14. Are Patients with Inflammatory Bowel Disease at Increased Risk of Coronary Artery Disease?
    Sumeet Gandhi, Neeraj Narula, John Kenneth Marshall, Michael E. Farkouh · 2012 · The American Journal of Medicine
  15. The IFN‐γ‐induced transcriptional program of the CIITA gene is inhibited by statins
    Sun J. Lee, Hongwei Qin, Etty N. Benveniste · 2008 · European Journal of Immunology
  16. Role of statins in the treatment of multiple sclerosis
    Rosella Ciurleo, Placido Bramanti, Silvia Marino · 2014 · Pharmacological Research
  17. A Novel Crosslinked Hyaluronic Acid Nanogel for Drug Delivery
    Sílvia Santos Pedrosa, Catarina Gonçalves, Laurent David, Miguel Gama · 2014 · Macromolecular Bioscience
  18. In vivo and in vitro effects of statins on lymphocytes in patients with Hashimoto’s thyroiditis
    Sevim Güllü, Rıfat Emral, Mehmet Baştemir, Arthur B. Parkes, John H. Lazarus · 2005 · European Journal of Endocrinology
  19. Pathology, natural history and treatment of abdominal aortic aneurysms
    Alexandra R. Zankl, Hardy Schumacher, Ulrike Krumsdorf, Hugo Albert Katus, L. Jahn, Christiane Tiefenbacher · 2006 · Clinical Research in Cardiology
  20. ACAT as a Drug Target for Alzheimer’s Disease
    Henri J. Huttunen, Dora M. Kovacs · 2008 · Neurodegenerative Diseases
  21. Treatment with anti‐inflammatory drugs in community‐acquired pneumonia
    Sabine C A Meijvis, Ewoudt M.W. van de Garde, Ger T. Rijkers, Willem Jan W. Bos · 2012 · Journal of Internal Medicine
  22. Biological effects of acute pravastatin treatment in patients after aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled trial
    Ming-Yuan Tseng, Peter J. Hutchinson, Carole L. Turner, Marek Czosnyka, Hugh K. Richards, John D. Pickard, Peter J. Kirkpatrick · 2007 · Journal of neurosurgery
  23. Statins do not improve short-term survival in an oriental population with sepsis
    Kai‐Chien Yang, Jung‐Yien Chien, Wei‐Kung Tseng, Po‐Ren Hsueh, Chong‐Jen Yu, Chau‐Chung Wu · 2007 · The American Journal of Emergency Medicine
  24. The Immunomodulatory Effects of Statins on Macrophages
    Sheridan, Alanah, Wheeler-Jones, Caroline P. D., Gage, Matthew C. · 2022 · Immuno
  25. Atorvastatin induces apoptosis by a caspase‐9‐dependent pathway: an in vitro study on activated rat hepatic stellate cells
    Isabella Aprigliano, József Dudás, Giuliano Pasquale Ramadori, Bernhard Saile · 2008 · Liver International
  26. Immunomodulatory effects of HMG-CoA reductase inhibitors.
    Farhad R. Danesh, Ramon Añel, Lixia Zeng, Jon W. Lomasney, Atul Sahai, Yashpal S. Kanwar · 2003 · PubMed
  27. Statin Therapy and Mortality in HIV-Infected Individuals; A Danish Nationwide Population-Based Cohort Study
    Line Dahlerup Rasmussen, Gitte Kronborg, Carsten Schade Larsen, Court Pedersen, Jan Gerstoft, Niels Obel · 2013 · PLoS ONE
  28. Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity
    Jae-Geun Lee, Dong Gu Kang, Jung Re Yu, Young Ree Kim, Jin Soek Kim, Gwan Pyo Koh, Dae Ho Lee · 2011 · Diabetes & Metabolism Journal
  29. Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritis
    Christina Charles‐Schoeman, Mona Lisa Banquerigo, Susan Y. Hama, Mohamad Navab, Grace S. Park, Brian J. Van Lenten, Alan C. Wagner, Alan M. Fogelman, Ernest Brahn · 2008 · Clinical Immunology
  30. Effect of Statins with α-Tricalcium Phosphate on Proliferation, Differentiation, and Mineralization of Human Dental Pulp Cells
    Parasuraman R. Varalakshmi, Mahendran Kavitha, Ramajayam Govindan, Srinivasan Narasimhan · 2013 · Journal of Endodontics
  31. Simvastatin Inhibits Staphylococcus aureus Host Cell Invasion through Modulation of Isoprenoid Intermediates
    Mary P. Horn, Sharmon M. Knecht, Frances L. Rushing, Julie A. Birdsong, Parker Siddall, Charron M. Johnson, Terri N. Abraham, Amy Brown, Catherine B. Volk, Kelly Gammon et al. · 2008 · Journal of Pharmacology and Experimental Therapeutics
  32. Effect of simvastatin on proinflammatory cytokines production during lipopolysaccharide-induced inflammation in rats.
    Lana Nežić, Ranko Škrbić, Silva Dobrić, Miloš P. Stojiljković, Svjetlana Stoisavljević Šatara, Zoran A. Milovanovic, Nataša Stojaković · 2009 · PubMed
  33. Simvastatin Enhances Protection against Listeria monocytogenes Infection in Mice by Counteracting Listeria-Induced Phagosomal Escape
    Suraj P. Parihar, Reto Guler, Dirk M. Lang, Harukazu Suzuki, Adrian David Marais, Frank Brombacher · 2013 · PLoS ONE
  34. Co-medications That Modulate Liver Injury and Repair Influence Clinical Outcome of Acetaminophen-Associated Liver Injury
    Ayako Suzuki, Nancy Yuen, John S.A. Walsh, Julie I. Papay, Christine M. Hunt, Anna Mae Diehl · 2009 · Clinical Gastroenterology and Hepatology
  35. Peripheral tolerance can be modified by altering KLF2-regulated Treg migration
    Sudheer K. Pabbisetty, Whitney Rabacal, Emmanuel J. Volanakis, Vrajesh V. Parekh, Danyvid Olivares–Villagómez, Delphine Cendron, Kelli Lynn Boyd, Luc Van Kaer, Eric Sebzda · 2016 · Proceedings of the National Academy of Sciences
  36. An in vitro model of foam cell formation induced by a stretchable microfluidic device
    Xiaoyang Gu, Shijie Xie, Dandan Hong, Yongsheng Ding · 2019 · Scientific Reports
  37. Statins Could Be Used to Control Replication of Some Viruses, Including HIV-1
    Caroline Gilbert, Marc Bergeron, Sylvie Méthot, Jean-François Giguère, Michel J. Tremblay · 2005 · Viral Immunology
  38. Biomarkers of heart transplant rejection: the good, the bad, and the ugly!
    Carlos Alberto Labarrere, Beate Roxane Jaeger · 2012 · Translational research
  39. Atherosclerosis, cholesterol, nutrition, and statins--a critical review.
    Jan‐Olaf Gebbers · 2007 · Europe PMC (PubMed Central)
  40. Association Between Statin Use and Endometrial Cancer Survival
    Nicole Suzanne Nevadunsky, Anne Van Arsdale, Howard D. Strickler, Lori Ann Spoozak, Alyson B. Moadel, Gurpreet Kaur, Eugenia Girda, Gary L. Goldberg, Mark H. Einstein · 2015 · Obstetrics and Gynecology
  41. Statins in ophthalmology
    Kenneth Ooi, Pauline Khoo, Veronika Vaclavik, Stephanie Louise Watson · 2019 · Survey of Ophthalmology
  42. Statin-mediated protective effects in the central nervous system: General mechanisms and putative role of stress proteins
    Christian W. Schmeer, Alexandra Kretz, Stefan Isenmann · 2006 · Restorative Neurology and Neuroscience
  43. Secretion of apolipoprotein E by brain glia requires protein prenylation and is suppressed by statins
    Asha Naidu, Qiang Xu, Rosanne Catalano, Barbara Cordell · 2002 · Brain Research
  44. Potential Role of Statins in Inflammation and Atherosclerosis
    Masayuki Yoshida · 2003 · Journal of Atherosclerosis and Thrombosis
  45. Antithrombotic actions of statins involve PECAM-1 signaling
    Leonardo A. Moraes, Sakthivel Vaiyapuri, Parvathy Sasikumar, Marfoua S. Ali, Neline Kriek, Tanya Sage, Jonathan M. Gibbins · 2013 · Blood
  46. Clinical Improvement in Psoriasis With Treatment of Associated Hyperlipidemia
    Ramin Ghazizadeh, Mamiko Tosa, M. Ghazizadeh · 2011 · American Journal of the Medical Sciences
  47. Phenotypic change of glomerular podocytes in primary focal segmental glomerulosclerosis: developmental paradigm?
    Akihiko Ohtaka · 2002 · Nephrology Dialysis Transplantation
  48. Lovastatin attenuates nerve injury in an animal model of Guillain–Barré syndrome
    Jason P. Sarkey, Michael P. Richards, Evan B. Stubbs · 2006 · Journal of Neurochemistry
  49. T Helper Cell Polarization in Healthy People: Implications for Cardiovascular Disease
    Nels C. Olson, Reem M. Sallam, Margaret F. Doyle, Russell P. Tracy, Sally Ann Huber · 2013 · Journal of Cardiovascular Translational Research
  50. Anti-hypertensive effects of Rosuvastatin are associated with decreased inflammation and oxidative stress markers in hypertensive rats
    Pierre Sicard, Stéphanie Delemasure, Claudia Korandji, Anabelle Sequeira-Le Grand, Benjamin Lauzier, Jean-Claude Guilland, Laurence Duvillard, Marianne Zeller, Yves Cottin, Catherine Vergely et al. · 2008 · Free Radical Research
  51. Immunomodulatory and Anti-Inflammatory Activities of Statins
    Emilia Mira, Santos Mañes · 2009 · Endocrine Metabolic & Immune Disorders - Drug Targets
  52. Immunomodulation by statins: Inhibition of cholesterol vs. isoprenoid biosynthesis
    Hedwich F. Kuipers, Peter J. van den Elsen · 2007 · Biomedicine & Pharmacotherapy
  53. Increased inflammatory markers in children with familial hypercholesterolaemia
    Thor Ueland, Maud N. Vissers, Albert Wiegman, Jessica Rodenburg, Barbara A. Hutten, Lars Lysgaard Gullestad, Leiv Ose, Nader Rifai, Paul M. Ridker, John J.P. Kastelein et al. · 2006 · European Journal of Clinical Investigation
  54. The effect of atorvastatin and its role on systemic cytokine network in treatment of acute experimental colitis.
    Aktunc, Erol, Kayhan, Basak, Arasli, Mehmet, Gun, Banu Dogan, Barut, Figen · 2011 · Immunopharmacology and Immunotoxicology
  55. Statins use and COVID-19 outcomes in hospitalized patients
    Samuel K. Ayeh, Enoch Joseph Abbey, Banda A. A. Khalifa, Richard D. Nudotor, Albert Danso Osei, Vignesh Chidambaram, Ngozi Osuji, Samiha Khan, Emmanuella L. Salia, Modupe O. Oduwole et al. · 2021 · PLoS ONE
  56. Statins induce suppressor of cytokine signaling‐3 in macrophages
    Kuo‐Chin Huang, Ching-Wen Chen, Jui-Ching Chen, Wan‐Wan Lin · 2003 · FEBS Letters
  57. Statin therapy of calcific aortic stenosis: hype or hope?
    Volker Liebe, Martina Brueckmann, Martin M. Borggrefe, Jens J. Kaden · 2006 · European Heart Journal
  58. Statins Inhibit Leukocyte Recruitment
    Brenda Renata Kwak, François Mach · 2001 · Arteriosclerosis Thrombosis and Vascular Biology
  59. Statin Modulation of Human T-Cell Proliferation, IL-1 and IL-17 Production, and IFN- T Cell Expression: Synergy with Conventional Immunosuppressive Agents
    Jameel, Ashmal, Ooi, Kenneth G.-J., Jeffs, Natasha R., Galatowicz, Grazyna, Lightman, Susan L., Calder, Virginia L. · 2013 · International Journal of Inflammation
  60. Lovastatin induces the formation of abnormal myelin‐like membrane sheets in primary oligodendrocytes
    Olaf Maier, Jenny De Jonge, Anita Nomden, Dick Hoekstra, Wia Baron · 2008 · Glia
  61. Atorvastatin Donor Pretreatment Prevents Ischemia/Reperfusion Injury in Renal Transplantation in Rats: Possible Role for Aldose-Reductase Inhibition
    Uwe Göttmann, Paul Thomas Brinkkoetter, Simone Hoeger, Katrin Gutermann, Zora Martins Coutinho, Tobias Friedrich Ruf, Song Hui, Zhenzi Liu, Peter Schnuelle, Fokko Johannes van der Woude et al. · 2007 · Transplantation
  62. Giant cell arteritis
    Jem V. Ninan, Susan Lester, Catherine Louise Hill · 2016 · Best Practice & Research Clinical Rheumatology
  63. Immune response to influenza vaccination in the elderly is altered by chronic medication use
    Divyansh Agarwal, Kenneth E. Schmader, Andrew V. Kossenkov, Susan A. Doyle, Raj K. Kurupati, Hildegund C.J. Ertl · 2018 · Immunity & Ageing
  64. A pravastatin dose-escalation study in systemic lupus erythematosus
    Karen H. Costenbader, Matthew H. Liang, Lori Beth Chibnik, Juliet Aizer, Hannah Kwon, Victoria Gall, Elizabeth W. Karlson · 2007 · Rheumatology International
  65. Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases?
    David W. McCarey, Naveed A. Sattar, Iain B. McInnes · 2005 · Arthritis Research
  66. Effect of atorvastatin and pravastatin on serum C-reactive protein
    Steven M. Kent, Patrick J. Flaherty, Louis C. Coyle, Thor T. Markwood, Allen J. Taylor · 2003 · American Heart Journal
  67. A Randomized Controlled Trial of Atorvastatin in Patients With Bronchiectasis Infected With Pseudomonas Aeruginosa
    Pallavi Bedi, James Duncan Chalmers, Catriona Graham, Andrea Clarke, Samantha Donaldson, Catherine J. Doherty, John R. W. Govan, Donald J. Davidson, Adriano Giorgio Rossi, Adam T. Hill · 2017 · CHEST Journal
  68. Atorvastatin added to interferon beta for relapsing multiple sclerosis: a randomized controlled trial
    Christian P. Kamm, Marwan El‐Koussy, Sebastian Humpert, Oliver Findling, Ferdinand von Bredow, Yuliya Burren, Guido Schwegler, Dagmar Schött, Filippo Donati, Martin Müller et al. · 2012 · Journal of Neurology
  69. Changes of the coronary arteries and cardiac microvasculature with aging: Implications for translational research and clinical practice
    Francesco Piccirillo, Myriam Carpenito, Giuseppe Verolino, Camilla Chello, Annunziata Nusca, Mario Lusini, Cristiano Spadaccio, Francesco Nappi, Germano Di Sciascio, Antonio Nenna · 2019 · Mechanisms of Ageing and Development
  70. The molecular basis of vulnerable plaque: potential therapeutic role for immunomodulation
    Robert L. Wilensky, Damir Hamamdzic · 2007 · Current Opinion in Cardiology
  71. Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease—A randomized, placebo-controlled study
    Hannes Franz Alber, Matthias Frick, Alois Suessenbacher, Jakob Doerler, Michael Schirmer, Eva-Maria Stocker, Wolfgang Dichtl, Otmar M. Pachinger, Franz F. Weidinger · 2005 · American Heart Journal
  72. Simvastatin inhibits IFN-γ-induced CD40 gene expression by suppressing STAT-1α
    Sun Jung Lee, Hongwei Qin, Etty N. Benveniste · 2007 · Journal of Leukocyte Biology
  73. Clustering of cardiovascular risk factors in rheumatoid arthritis: the rationale for using statins.
    Irene F. Gazi, Boumpas Dt, Dimitri P. Mikhailidis, Emmanuel S. Ganotakis · 2007 · PubMed
  74. Statin therapy and stroke prevention
    Carl J. Vaughan, Norman Delanty, Craig T. Basson · 2001 · Current Opinion in Cardiology
  75. The Effect of Statins on Mortality in Septic Patients: A Meta-Analysis of Randomized Controlled Trials
    Laura Pasin, Giovanni Landoni, Maria Lourdes Castro, Luca Cabrini, Alessandro Belletti, Paolo Feltracco, Gabriele Finco, Andrea Carozzo, Roberto Chiesa, Alberto Zangrillo · 2013 · PLoS ONE
  76. Statin-mediated reduction of osteopontin expression induces apoptosis and cell growth arrest in ovarian clear cell carcinoma
    Motoki Matsuura · 2010 · Oncology Reports
  77. Immunomodulator Activity of 3-Hydroxy-3-Methilglutaryl-CoA Inhibitors
    Costantino Smaldone, Salvatore Brugaletta, Vincenzo Pazzano, Giovanna Liuzzo · 2009 · Cardiovascular & Hematological Agents in Medicinal Chemistry
  78. Patients with calcific aortic stenosis exhibit systemic molecular evidence of ischemia, enhanced coagulation, oxidative stress and impaired cholesterol transport
    Laura Mouriño-Álvarez, Montserrat Baldan Martin, Laura Gonzalez‐Calero, Carlos Martínez-Laborde, Tamara Sastre-Oliva, Rafael Moreno‐Luna, Luis Fernando Lopez-Almodovar, Pedro Luis Sanchez, Francisco Fernández‐Avilés, Fernando Vivanco et al. · 2016 · International Journal of Cardiology
  79. Immune regulatory effects of simvastatin on regulatory T cell-mediated tumour immune tolerance
    Sung Yong Lee, J Y Moon, Haneul Choi, H O Kim, Gyu Young Hur, K H Jung, S. Y. Lee, J H Kim, C Shin, Joongwon Shim et al. · 2010 · Clinical & Experimental Immunology
  80. Natural Products as Pharmaceuticals and Sources for Lead Structures
    David J. Newman, Gordon M. L. Cragg, David G. I. Kingston · 2008 · Elsevier eBooks
  81. Atorvastatin interferes with activation of human CD4+ T cells via inhibition of small guanosine triphosphatase (GTPase) activity and caspase-independent apoptosis
    P-T Brinkkoetter, Uwe Göttmann, Johannes Hubertus Schulte, Fokko Johannes van der Woude, C Braun, Benito Antonio Yard · 2006 · Clinical & Experimental Immunology
  82. Correlates of endothelial function and their relationship with inflammation in patients with familial hypercholesterolaemia
    Paul L. van Haelst, Jasper J. van Doormaal, Folkert Wouter Asselbergs, Arie M. van Roon, Nic J.G.M. Veeger, Maureen M. Henneman, Andries Jan Smit, Jan Willem Cohen Tervaert, Johan F. May, Rijk O. B. Gans · 2003 · Clinical Science
  83. Hyperlipidemia is a risk factor for lymphatic metastasis in superficial esophageal carcinoma
    Akihiro Sako, Joji Kitayama, Shoichi Kaisaki, Hirokazu Nagawa · 2004 · Cancer Letters
  84. Repurposing Treatments to Enhance Innate Immunity. Can Statins Improve Neutrophil Functions and Clinical Outcomes in COPD?
    Georgia Walton, James A. Stockley, Diane Griffiths, Charandeep Sadhra, Thomas Purvis, Elizabeth Sapey · 2016 · Journal of Clinical Medicine
  85. Regulation of different inflammatory diseases by impacting the mevalonate pathway
    Robert Zeiser, Kristina Maas‐Bauer, Sawsan Youssef, Christoph Dürr, Lawrence Steinman, Robert S. Negrin · 2008 · Immunology
  86. Simvastatin inhibits secretion of T h17‐polarizing cytokines and antigen presentation by DC s in patients with relapsing remitting multiple sclerosis
    Xin Zhang, Yazhong Tao, Jinzhao Wang, Rafael García‐Mata, Silva Markovic‐Plese · 2012 · European Journal of Immunology
  87. Atorvastatin affects TLR4 clustering via lipid raft modulation
    Praveen Chansrichavala, Udom Chantharaksri, Piyamitr Sritara, Nathamon Kosoltanapiwat, Sansanee C. Chaiyaroj · 2010 · International Immunopharmacology
  88. Angiotensin converting enzyme inhibitor but not angiotensin receptor blockade or statin ameliorates murine adriamycin nephropathy
    Sydney C.W. Tang, Joseph C.K. Leung, Loretta Y.Y. Chan, Allison A. Eddy, Kar Neng Lai · 2007 · Kidney International
  89. Does fluvastatin favour HCV replication in vivo? A pilot study on HIV–HCV coinfected patients
    Laura Milazzo, Luca Meroni, Morena Galazzi, Miriam Cesari, Ilaria Caramma, Giulia Carla Marchetti, Massimo Galli, Spinello Antinori · 2009 · Journal of Viral Hepatitis
  90. Inhibitory effects of fluvastatin on cytokine and chemokine production by peripheral blood mononuclear cells in patients with allergic asthma
    Karen Thursday R. Samson, Kenji Minoguchi, Akihiko Tanaka, Naruhito Oda, Takuya Yokoe, Yoshitaka Yamamoto, Masahide Yamamoto, Shin Ohta, Mitsuru Adachi · 2006 · Clinical & Experimental Allergy
  91. Neurodegeneration in autoimmune demyelination: Recent mechanistic insights reveal novel therapeutic targets
    Orhan Aktaş, Sonia Waiczies, Frauke Zipp · 2007 · Journal of Neuroimmunology
  92. Anti-amyloidogenic effect of Allium sativum in Alzheimer’s transgenic model Tg2576
    Chauhan, Neelima B. · 2003 · Journal of Herbal Pharmacotherapy
  93. Inhibition of Protein Geranylgeranylation Specifically Interferes with CD40-Dependent B Cell Activation, Resulting in a Reduced Capacity To Induce T Cell Immunity
    Alexander Shimabukuro‐Vornhagen, Shahram Zoghi, Tanja M. Liebig, Kerstin Wennhold, Jens Chemitz, Andreas Draube, Matthias Kochanek, Florian Blaschke, Christian Philipp Pallasch, Udo Holtick et al. · 2014 · The Journal of Immunology
  94. HMG-CoA reductase inhibitors pravastatin, lovastatin and simvastatin suppress delayed rectifier K+-channel currents in murine thymocytes
    Itsuro Kazama, Asuka Baba, Yoshio Maruyama · 2014 · Pharmacological Reports
  95. Simvastatin Attenuates Trinitrobenzene Sulfonic Acid-Induced Colitis, but Not Oxazalone-Induced Colitis
    Maho Ikeda, Fuminao Takeshima, Hajime Isomoto, Saburo Shikuwa, Yohei Mizuta, Yoshiyuki Ozono, Shigeru Kohno · 2007 · Digestive Diseases and Sciences
  96. Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study
    Laura Milazzo, Ilaria Caramma, Cristina Mazzali, Miriam Cesari, M. Olivetti, Massimo Galli, Spinello Antinori · 2010 · Journal of Antimicrobial Chemotherapy
  97. Bronchiectasis
    Pamela J. McShane, Gregory Tino · 2018 · CHEST Journal
  98. Reduced Risk of Poststroke Pneumonia in Thrombolyzed Stroke Patients with Continued Statin Treatment
    Jan Friedrich Scheitz, Matthias Endres, Peter Ulrich Heuschmann, Heinrich J. Audebert, Christian Hans Nolte · 2012 · International Journal of Stroke
  99. Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis
    Xueyan Peng, Jianping Jin, Shailendra Giri, Mônica Montes, Danuta Sujkowski, Yunan Tang, Jennifer Smrtka, Timothy L. Vollmer, Inderjit Singh, Silva Markovic‐Plese · 2006 · Journal of Neuroimmunology
  100. Fluvastatin attenuates severe hemorrhagic shock-induced organ damage in rats
    Chia‐Chi Lee, Ru‐Ping Lee, Yi‐Maun Subeq, Chung‐Jen Lee, Tse‐Min Chen, Bang‐Gee Hsu · 2009 · Resuscitation